Wooldridge James 4
4 · Aeglea BioTherapeutics, Inc. · Filed Feb 22, 2018
Insider Transaction Report
Form 4
Wooldridge James
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-02-20+45,000→ 45,000 totalExercise: $6.31Exp: 2028-02-19→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 20, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.